Notice: 21253687
Notice of Proposed Rule
Department: DEPARTMENT OF LEGAL AFFAIRS
Chapter: SCHEDULING AND RESCHEDULING OF CONTROLLED SUBSTANCES

VIEW NOTICE

Overview

RULE:
2-40.007   Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) Derived from Cannabis and No More Than 0.1 Percent (w/w) Residual Tetrahydrocannabinols
RULEMAKING AUTHORITY: 893.0355, FS.
LAW: 893.0355, FS.
PRINT PUBLISH DATE: 12/13/2018   Vol. 44/241
COMMENTS: From 12/13/2018 To 1/3/2019 (21 Days)
The public comment period for this notice has already expired.
REFERENCE MATERIALS: No reference(s).